699 related articles for article (PubMed ID: 22616869)
21. Novel targets in M. tuberculosis: search for new drugs.
Lamichhane G
Trends Mol Med; 2011 Jan; 17(1):25-33. PubMed ID: 21071272
[TBL] [Abstract][Full Text] [Related]
22. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
Tomioka H
Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
[TBL] [Abstract][Full Text] [Related]
23. The future for early-stage tuberculosis drug discovery.
Zuniga ES; Early J; Parish T
Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534
[TBL] [Abstract][Full Text] [Related]
24. Vitamins Based Novel Target Pathways/Molecules as Possible Emerging Drug Targets for the Management of Tuberculosis.
Sharma A; Jain K; Flora SJS
Med Chem; 2018; 14(3):212-224. PubMed ID: 29110620
[TBL] [Abstract][Full Text] [Related]
25. Medicine. New TB drug promises shorter, simpler treatment.
Cohen J
Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
[No Abstract] [Full Text] [Related]
26. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
[TBL] [Abstract][Full Text] [Related]
27. Improving the tuberculosis drug development pipeline.
Evangelopoulos D; McHugh TD
Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
[TBL] [Abstract][Full Text] [Related]
28. New perspectives on natural products in TB drug research.
Pauli GF; Case RJ; Inui T; Wang Y; Cho S; Fischer NH; Franzblau SG
Life Sci; 2005 Dec; 78(5):485-94. PubMed ID: 16243360
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs.
Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B
Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082
[TBL] [Abstract][Full Text] [Related]
30. Host-pathogen systems for early drug discovery against tuberculosis.
Trofimov V; Costa-Gouveia J; Hoffmann E; Brodin P
Curr Opin Microbiol; 2017 Oct; 39():143-151. PubMed ID: 29179041
[TBL] [Abstract][Full Text] [Related]
31. Overcoming the global crisis: "yes, we can", but also for TB ... ?
Ottenhoff TH
Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
[TBL] [Abstract][Full Text] [Related]
32. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.
Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D
Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169
[TBL] [Abstract][Full Text] [Related]
33. Structure-Function Analysis of the Essential
Padayachee T; Lamb DC; Nelson DR; Syed K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
[TBL] [Abstract][Full Text] [Related]
34. Recent advances for identification of new scaffolds and drug targets for Mycobacterium tuberculosis.
Dhiman R; Singh R
IUBMB Life; 2018 Sep; 70(9):905-916. PubMed ID: 29761628
[TBL] [Abstract][Full Text] [Related]
35.
Sawicki R; Ginalska G
Future Med Chem; 2019 Aug; 11(16):2193-2203. PubMed ID: 31538522
[TBL] [Abstract][Full Text] [Related]
36. The challenge of new drug discovery for tuberculosis.
Koul A; Arnoult E; Lounis N; Guillemont J; Andries K
Nature; 2011 Jan; 469(7331):483-90. PubMed ID: 21270886
[TBL] [Abstract][Full Text] [Related]
37. Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS; Wright A; Bai GH; Barrera L; Boulahbal F; Martín-Casabona N; Drobniewski F; Gilpin C; Havelková M; Lepe R; Lumb R; Metchock B; Portaels F; Rodrigues MF; Rüsch-Gerdes S; Van Deun A; Vincent V; Laserson K; Wells C; Cegielski JP
Emerg Infect Dis; 2007 Mar; 13(3):380-7. PubMed ID: 17552090
[TBL] [Abstract][Full Text] [Related]
38. Computational medicinal chemistry for rational drug design: Identification of novel chemical structures with potential anti-tuberculosis activity.
Koseki Y; Aoki S
Curr Top Med Chem; 2014; 14(1):176-88. PubMed ID: 24236720
[TBL] [Abstract][Full Text] [Related]
39. TB drug development: immunology at the table.
Nathan C; Barry CE
Immunol Rev; 2015 Mar; 264(1):308-18. PubMed ID: 25703568
[TBL] [Abstract][Full Text] [Related]
40. Guanosine triphosphatases as novel therapeutic targets in tuberculosis.
Rajni ; Meena LS
Int J Infect Dis; 2010 Aug; 14(8):e682-7. PubMed ID: 20207570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
